PrEP

;

Trump budget proposes over $1.5 billion cut to domestic HIV programs

Apr 3, 2026

Congress rejected these massive attacks on HIV prevention last year and we will urge them to do the same again this year. While we are reassured that over 600,000 low-income people currently accessing care and treatment through the Ryan White HIV/AIDS Program and those using PrEP programs in community health centers can maintain their services, the dismantling of HIV prevention and surveillance and other programs will just lead to more HIV infections and higher health costs down the road.

read more

Comprehensive national PrEP bills to prevent HIV introduced

Mar 4, 2026

We thank the leadership of Sens. Smith and Schiff and Reps. Takano, Balint and Pocan in reintroducing the PrEP Access and Coverage Act,” commented Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “Passage of this bill will greatly expand access to PrEP for people who have health coverage across all payers and create a national grant program that includes community and provider outreach as well as PrEP drugs and associated services for the uninsured. We have a national HIV treatment program, but in order to end HIV, we need a comprehensive national HIV PrEP program.

read more

HIV+Hep praises DC for protecting PrEP access

Feb 3, 2026

Thanks to the leadership of Councilmembers Zachary Parker and Christina Henderson, DC residents who are at risk of HIV will be able to access all forms of PrEP without cost-sharing or prior authorization. This is particularly important since federal preventive health requirements have recently come under attack. We are especially grateful for the amendment to the bill that will require insurers to cover all PrEP drugs, including new long-acting regimens.

read more

Congress funds domestic HIV programs—Trump administration must now implement them

Jan 20, 2026

After a tumultuous year of proposed program cuts and eliminations, Congress has agreed to reject them and instead has maintained funding for domestic HIV prevention and treatment programs on a bipartisan basis. Now, the Trump administration must focus its attention on properly implementing these programs in order to get the nation back on track to end HIV in the U.S.

read more

CVS Health decides to cover new long-acting PrEP drug

Jan 13, 2026

“We are pleased that CVS Health has finally decided to cover this groundbreaking new PrEP medication. Four months ago, 63 HIV organizations joined us in sending a letter to CVS’s president urging them to reconsider their refusal to cover Yeztugo and reminding them of their legal obligation to cover PrEP and describe the important benefits the drug would bring to preventing HIV in the US.  With this coverage decision, CVS joins other leading payers and PBMs in covering the new medication.”

read more

Search

Press Release Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B Hepatitis C hepatits HIV HIV Prevention hous housing insurer Insurers LGBT Medicaid Medicare Part D NAIC NIH PBMs PrEP Prescription Drugs prevention Private Insurance Ryan White Ryan White Program state Syringe services Testing transparency Treatment Trump administration

Recent Press Releases

Pin It on Pinterest